Venous thromboembolism, cancer and low molecular weight heparin

Authors	R.J.K. Hettiarachchi
Supervisors	H.R. Büller
Cosupervisors	M.H. Prins
Award date	05-09-2000
ISBN	90901402298
Number of pages	128
Organisations	Faculty of Medicine (AMC-UvA)
Document type	PhD thesis
Note	Research conducted at: CRIA
Language	English
Downloads	Thesis Cover Titlepage CONTENTS Chapter 1 INTRODUCTION Chapter 2 Undiagnosed malignancy in patients with deep vein Thrombosis. Incidence, risk indicators and diagnosis Chapter 3 Newly diagnosed malignancy in patients with venous thromboembolism. Search or wait and see? Chapter 4 Subsequent diagnosis of malignancy in patients presenting with venous thromboembolism. A review and an analysis of number needed to screen Chapter 5 Low molecular weight heparin versus unfractionated heparin in the initial treatment of venous thromboembolism Chapter 6 Do Heparins Do More than Just Treat Thrombosis? The Influence of heparins on cancer spread Chapter 7 The effects of unfractionated heparin on survival in patients with malignancy. A systematic review Chapter 8 Does low molecular weight heparin improve the survival of cancer patients? An interim safety report of a randomized double blind placebo controlled study SUMMARY SAMENVATTING CO-AUTHORS ACKNOWLEDGMENTS CURRICULUM VITAE Cover
Permalink to this page

Back

UvA-DARE